SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection
no abstract available Aknowledgements: We thank professor Nathan Tubliz, dept. Biology, University of Oregon, for his insightful support.
Saved in:
Main Authors: | Elisabetta Abruzzese, luigia luciano, Francesco D'Agostino, Malgorzata Monika Trawinska, Fabrizio Pane, Paolo de Fabritiis |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-04-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://mjhid.org/index.php/mjhid/article/view/4223 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE
by: Gianfranco Catalano, et al.
Published: (2020-10-01) -
Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML)
by: Ibrahim C. Haznedaroglu
Published: (2014-08-01) -
Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia
by: Aytan Shirinova
Published: (2024-03-01) -
Dilemmas in the Diagnosis and Management of CML in Pakistan
by: Sahrish Khan, et al.
Published: (2024-12-01) -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA
by: Buket Altinok Gunes, et al.
Published: (2023-01-01)